SG Americas Securities
KRTX

SG Americas Securities’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

SG Americas Securities’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-174,193
Closed -$55.1M – 3576
2023
Q4 		$55.1M Buy
174,193
+167,448
+2,483% +$32.5M 0.51% 33
2023
Q3 		$1.14M Buy
6,745
+5,779
+598% +$1.09M 0.01% 1162
2023
Q2 		$209K Sell
966
-7,862
-89% -$1.68M ﹤0.01% 1779
2023
Q1 		$1.6M Buy
8,828
+1,227
+16% +$235K 0.02% 807
2022
Q4 		$1.49M Buy
7,601
+483
+7% +$104K 0.02% 712
2022
Q3 		$1.6M Sell
7,118
-13,054
-65% -$2.64M 0.02% 703
2022
Q2 		$2.55M Buy
20,172
+11,785
+141% +$1.35M 0.03% 606
2022
Q1 		$1.06M Sell
8,387
-2,538
-23% -$286K 0.01% 1384
2021
Q4 		$1.43M Buy
10,925
+4,796
+78% +$620K 0.01% 1361
2021
Q3 		$750K Buy
6,129
+2,801
+84% +$323K ﹤0.01% 2157
2021
Q2 		$379K Sell
3,328
-2,155
-39% -$252K ﹤0.01% 2063
2021
Q1 		$659K Sell
5,483
-47,062
-90% -$5.33M ﹤0.01% 1820
2020
Q4 		$5.34M Buy
52,545
+20,046
+62% +$1.86M 0.03% 473
2020
Q3 		$2.51M Buy
32,499
+24,148
+289% +$2.06M 0.02% 617
2020
Q2 		$931K Buy
8,351
+4,399
+111% +$382K 0.01% 1475
2020
Q1 		$285K Buy
+3,952
New +$338K ﹤0.01% 2274

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

SG Americas Securities's KRTX Position: Q1 2024 in Review

SG Americas Securities sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 174,193 shares — an estimated $55.1M sold.

SG Americas Securities first reported a position in KRTX in Q1 2020 and held it in 16 quarters. The position peaked at $55.1M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • SG Americas Securities reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • SG Americas Securities sold 174,193 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $55.1M.
  • SG Americas Securities first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 16 quarters.
  • SG Americas Securities's Karuna Therapeutics, Inc. Common Stock position peaked at $55.1M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on SG Americas Securities's 13F filing for Q1 2024, filed 6 May 2024.